Home  /  Resource Library  /  Matchingadjusted indirect comparisons of axicabtagene ciloleucel to mosunetuzumab for the treatment of relapsed/refractory follicular lymphoma

Matchingadjusted indirect comparisons of axicabtagene ciloleucel to mosunetuzumab for the treatment of relapsed/refractory follicular lymphoma

Match comparison study examined mosunetuzumab versus CAR T Axicabtagene ciloleucel for treatment of relapsed follicular lymphoma.